These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 6299908

  • 1. [Clinical use of antiandrogens in the female].
    Moltz L, Schwartz U, Hammerstein J.
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of moderately severe virilism of women with Diane and Androcur 10].
    Döring HF, Ilgner M.
    Z Hautkr; 1983 May 15; 58(10):761-7. PubMed ID: 6224353
    [Abstract] [Full Text] [Related]

  • 3. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
    Falsetti L, Dordoni D, Gastaldi C, Gastaldi A.
    Acta Eur Fertil; 1986 May 15; 17(1):19-25. PubMed ID: 2941960
    [Abstract] [Full Text] [Related]

  • 4. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J, Huber J, Schmidt JB.
    Geburtshilfe Frauenheilkd; 1986 Jul 15; 46(7):435-8. PubMed ID: 3093307
    [Abstract] [Full Text] [Related]

  • 5. Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: efficacy, metabolic and endocrine effects.
    van Wayjen RG, van den Ende A.
    Exp Clin Endocrinol Diabetes; 1995 Jul 15; 103(4):241-51. PubMed ID: 7584530
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec 15; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 7. Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia.
    Nardi M, De Aloysio D, Busacchi P, Flamigni C.
    Acta Eur Fertil; 1975 Jun 15; 6(2):153-65. PubMed ID: 127497
    [Abstract] [Full Text] [Related]

  • 8. [Management of virilization with an antiandrogen-containing contraceptive].
    Apró G, Sas M.
    Orv Hetil; 1981 Jul 26; 122(30):1821-4. PubMed ID: 6458007
    [Abstract] [Full Text] [Related]

  • 9. [Anti-androgens. Their use in dermatology].
    Montero ED, Arevalo A, Michelotti M.
    Med Cutan Ibero Lat Am; 1981 Jul 26; 9(4):275-84. PubMed ID: 6456390
    [Abstract] [Full Text] [Related]

  • 10. [The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate].
    Grund E, Schmidt-Elmendorff H.
    Med Welt; 1975 Nov 28; 26(48):2180-7. PubMed ID: 128684
    [Abstract] [Full Text] [Related]

  • 11. [Medium-dose oral cyproterone acetate therapy in women with moderate androgenization. Results of a multicenter double-blind study].
    Moltz L, Kaiser E.
    Geburtshilfe Frauenheilkd; 1984 Jan 28; 44(1):47-52. PubMed ID: 6230282
    [Abstract] [Full Text] [Related]

  • 12. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
    van Vloten WA, van Haselen CW, van Zuuren EJ, Gerlinger C, Heithecker R.
    Cutis; 2002 Apr 28; 69(4 Suppl):2-15. PubMed ID: 12096825
    [Abstract] [Full Text] [Related]

  • 13. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
    Kaiser E.
    Geburtshilfe Frauenheilkd; 1986 Oct 28; 46(10):738-42. PubMed ID: 2948866
    [Abstract] [Full Text] [Related]

  • 14. [Clinical findings with a low-dosed antiandrogene (cyproteronacetate) and aethinyloestradiol women with virilising symptoms (author's transl)].
    Schmidt-Elmendorff H, Steyer M.
    Geburtshilfe Frauenheilkd; 1977 Apr 28; 37(4):297-303. PubMed ID: 140094
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F, Sahin I, Güler S, Demirbas B, Culha C, Serter R, Aral Y, Bavbek N.
    Adv Ther; 2008 Apr 28; 25(4):321-8. PubMed ID: 18389188
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of virilized women with intramuscular administration of cyproterone acetate].
    Moltz L, Haase F, Schwartz U, Hammerstein J.
    Geburtshilfe Frauenheilkd; 1983 May 28; 43(5):281-7. PubMed ID: 6223851
    [Abstract] [Full Text] [Related]

  • 17. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P, Morer F, Ordoñez J, Rodriguez J.
    Int J Clin Pharmacol Res; 1983 May 28; 3(2):129-35. PubMed ID: 6237068
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of acne and seborrhea using antiandrogens].
    Keller PJ, Fetz A, Schär A, Floersheim Y.
    Schweiz Med Wochenschr; 1978 Oct 21; 108(42):1640-2. PubMed ID: 151916
    [Abstract] [Full Text] [Related]

  • 19. On treating acne vulgaris with antiandrogens.
    Poláchová I.
    Acta Univ Palacki Olomuc Fac Med; 1991 Oct 21; 129():133-8. PubMed ID: 1837655
    [Abstract] [Full Text] [Related]

  • 20. [Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
    Marianowski L, Cyganek A, Grzechocińska B.
    Wiad Lek; 1994 Oct 21; 47(19-20):745-6. PubMed ID: 7483620
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.